Professional Documents
Culture Documents
Peripheral Vascular Disease: Aditya Adella Pratama G1A220012 Dr. Amran Sinaga, Sp. B
Peripheral Vascular Disease: Aditya Adella Pratama G1A220012 Dr. Amran Sinaga, Sp. B
Peripheral Vascular Disease: Aditya Adella Pratama G1A220012 Dr. Amran Sinaga, Sp. B
Disease
Aditya Adella Pratama
G1A220012
Interpretation
Accepted clinical applications for the use Vessels are classified into 1 of
of duplex: 4 groups :
Keuntungan : Kekurangan
• Non-invasive • Exposure to radiation, which can
• Shorter acquisition times and accumulate with repeated studies and be
thinner slices potentially carcinogenic,
• Higher spatial resolution • Necessity of giving iodinated contrast,
• Enable scanning of the whole which can be problematic for those
vascular tree in a limited period of patients with kidney disease.
time with a smaller • Some patients also have allergies to iodine
• Less patient contraindications
Evaluation
Magnetic resonance angiography (MRA)
Keunggulan : Kekurangan :
• Intravenous contrast is not • If a patient has a pacemaker
standardly needed that is not compatible with
• It does not utilize ionizing magnetic resonance imaging
radiation. (MRI), claustrophobic, or have
• Detect blood by its movement other metallic implants, MRI
compared with static might be contraindicated.
surrounding tissue. • Risk of nephrogenic systemic
• Non-invasive fibrosis with the administration
of gadolinium
Evaluation
Conventional Angiography
• Conventional angiography is the gold standard for diagnosis in PAD
• This modality involves the intravascular injection of a contrast agent during
planar radiographic imaging.
• Allows only the opacified arterial system to be seen on the final image.
• DSA is able to provide superior contrast resolution with lower doses of
intravenous contrast, while also having the ability to magnify images and image
vessels in real-time
Diagnosis
Diagnosis
Management
Differential Diagnosis
Neurological
Nerve root compression
Spinal stenosis
Vascular
Peripheral neuropathy
• Nerve entrapment Chronic venous insufficiency
Thrombophlebitis
Musculoskeletal Deep venous thrombosis
Medial tibial stress syndrome Raynaud phenomenon
Osteoarthritis • Thromboangiitis obliterans
Muscle strain
• Baker cyst
Prognosis
• The overall prognosis of PVD must take into account patient
risk factors, cardiovascular health, and disease severity.
• In terms of limb health at 5 years, 80% of patients will have
stable claudication symptoms.
• Only 1-2% of patients will progress to critical limb ischemia
in 5 years.
• 20% to 30% of patients with PAD will die within 5 years,
with 75% of those deaths attributed to cardiovascular causes
Complication
Acute coronary syndrome
Stroke
Nonhealing ulcer
Gangrene
Amputation
Deep vein thrombosis
• Erectile dysfunction
CONCLUTION
• PVD specifically lower limb peripheral arterial disease,
can be defined as atheromatous narrowing or
occlusion of an artery or arteries in the lower limb
• PVD manifestation was intermitten claudikation adn
crotical lim ischemia
• For diagnosis consisted of hystory of risk factors,
physical examination and ABI measurement
• Newer imaging modalities for diagnosis have since
emerged, which consist of magnetic resonance
angiography and, more recently, computed
tomography angiography
THANK YOU FOR YOUR ATTENTION